Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.

Vaccines (Basel) · 2022 · PMC8877446 · PMID 35214610

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

showed a trendp = 0.02actually significant

Moreover, HU showed a trend towards lowering the number of acute pain visits to the emergency department for patients with SCD affected by COVID-19 (CI 0.76–0.98, p = 0.02).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.